# OnCo record sunlight (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/sunlight/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "sunlight", "NCT04737187" ;
  schema:name "SUNLIGHT"@en ;
  schema:description "Adding the old blood-vessel antibody to a late-line chemotherapy pill extended survival by three months in patients who had exhausted standard options."@en ;
  schema:url <https://onco.cc/trials/sunlight/> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT04737187> ;
  onco:status "positive" ;
  onco:phase "3" ;
  schema:startDate "2020-11-25" ;
  onco:cancers <https://onco.cc/cancers/colorectal/> ;
  onco:technologies <https://onco.cc/technologies/cytotoxic-chemotherapy/> ;
  onco:targets <https://onco.cc/targets/vegf/> ;
  onco:drugs <https://onco.cc/drugs/trifluridine-tipiracil/>, <https://onco.cc/drugs/bevacizumab/> ;
  onco:companies <https://onco.cc/companies/servier/> ;
  onco:trials <https://onco.cc/trials/recourse/>, <https://onco.cc/trials/correct/>, <https://onco.cc/trials/fresco/> ;
  onco:people <https://onco.cc/people/kim-tae-won/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-prager-sunlight-trifluridine-tipiracil-bevacizumab-nejm-2023/> .
